Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Declines By 36.1%

Cosmos Health Inc. (NASDAQ:COSM) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 363,500 shares, a drop of 36.1% from the October 15th total of 568,500 shares. Based on an average daily volume of 487,900 shares, the short-interest ratio is currently 0.7 days. Currently, 2.0% of the shares of the stock are sold short.

Cosmos Health Price Performance

Shares of NASDAQ:COSM traded down $0.02 during trading hours on Friday, hitting $0.63. 132,921 shares of the company’s stock traded hands, compared to its average volume of 837,910. Cosmos Health has a 52 week low of $0.47 and a 52 week high of $1.65. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.17 and a current ratio of 1.35. The company’s fifty day simple moving average is $0.84 and its two-hundred day simple moving average is $0.90. The company has a market cap of $14.65 million, a price-to-earnings ratio of -0.28 and a beta of 5.72.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings data on Tuesday, August 20th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.05. Cosmos Health had a negative net margin of 38.19% and a negative return on equity of 5.83%. The company had revenue of $13.21 million during the quarter, compared to analyst estimates of $15.25 million. As a group, equities analysts anticipate that Cosmos Health will post -0.48 EPS for the current fiscal year.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.